Brett Lauring
8PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 08, 2019
Long-term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104-week VERTIS MET trial.Silvina Gallo, Bernard Charbonnel, Allison Goldman
|Feb 09, 2018
Long-term efficacy and safety of ertugliflozin monotherapy in patients with inadequately controlled T2DM despite diet and exercise: VERTIS MONO extension study.Ronnie Aronson, Juan Frias, Allison Goldman
|Jan 10, 2018
Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized Study.Sam Miller, Tania Krumins, Haojin Zhou
|Dec 29, 2017
Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study.Priscilla Hollander, Jie Liu, Julie Hill
|Dec 22, 2017
Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trial.Richard E Pratley, Roy Eldor, Annaswamy Raji
|Nov 22, 2017
Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study.George Grunberger, Sarah Camp, Jeremy Johnson
Pageof 2
